Rubius Therapeutics

Rubius Therapeutics

Rubius Therapeutics

Enucleated cell therapeutics
Raised
$461.1M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$241,100,000
IPO - 2018
$100,000,000
Venture capital - 2018
Team Size
1–10
Employees
PE HUB

Rubius Therapeutics goes public

Stock markets
$241,100,000 IPO
Xconomy

Rubius Upsizes IPO and Hauls in $241M for Red Blood Cell Therapies

Health Science
$100,000,000 Venture capital
FinSMEs

Rubius Therapeutics Closes $100M Financing

Health Funding Technology
$120,000,000 Venture capital (Series B)
BostonGlobe.com , businesswire

Biotech startup Rubius raises $120 million to develop red cell technology - The Boston Globe